16
Participants
Start Date
November 30, 2013
Primary Completion Date
November 30, 2015
Study Completion Date
November 30, 2015
Trichuris suis ova (TSO)
Six doses of TSO orally over a ten-week period (e.g., every 2 weeks x 10 weeks for a total of 6 total doses)
Placebo
Six doses of TSO placebo orally over a ten-week period (e.g., every 2 weeks x 10 weeks for a total of 6 total doses)
Weill Cornell Medical College, New York
University of Pittsburgh, Pittsburgh
Drexel University, Philadelphia
University of Maryland, Baltimore
Duke University Medical Center, Durham
University of Miami Miller School of Medicine, Miami
Vanderbilt University, Nashville
Cleveland Clinic, Cleveland
University of Iowa Hospital, Iowa City
Mayo Clinic, Rochester
Northwestern University Feinberg School of Medicine, Chicago
University of Chicago, Chicago
Baylor College of Medicine, Houston
Stanford University School of Medicine, Palo Alto
Virginia Mason Medical Center, Seattle
Yale University, New Haven
Tufts Medical Center, Boston
Collaborators (1)
Coronado Biosciences, Inc.
INDUSTRY
Autoimmunity Centers of Excellence
OTHER
National Institute of Allergy and Infectious Diseases (NIAID)
NIH